Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Adjunctive versus replacement zonisamide in adults with focal epilepsy
2009-010895-64Phase 4Completed
- Sponsor
- Eisai Co., Ltd.
- Start
- Apr 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of zonisamide in Focal Onset Epilepsy (2 arms), sponsored by Eisai Co., Ltd. Primary endpoint: Cumulative probability of withdrawing from the assigned treatment arm. Started Apr 2009; status: completed.
02
Drugs
zonisamide
03
Conditions
Focal Onset Epilepsy
Beyond the preview
Go deeper on 2009-010895-64.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2009-010895-64.